[ad_1] CHICAGO – Treatment with Sodium Glucose Cotransporter-2 (SGLT2) inhibitor empagliflozin (Jardiance, Boehringer Ingelheim / Lilly) is associated with beneficial effects on the left ventricular (LV) structure and function in patients with …
Read More »
[ad_1] A global survey showed that 2 out of 3 people with type 2 diabetes had cardiovascular disease (CVD) or had risk factors for CVD. the Take diabetes at heart The survey …
Read More »
[ad_1] More than two servings of dairy products per day were associated with lower risk of CVD and death, according to new data published in The Lancet. Of the 136,384 participants in …
Read More »